The data were revealed in advance of this year's annual ASCO cancer congress, which starts on Friday. "I see many patients with obesity, and given the clear link between cancer and obesity ...

The American Society of Clinical Oncology (ASCO) and Google Cloud have recently launched an artificial intelligence (AI)–powered search tool to provide accurate and fast access to ASCO’s full ...

The American Society of Clinical Oncology (ASCO) will be among the first to implement this new technology with the ASCO Guideline Generator, which is set for early adoption at the 2025 ASCO Annual ...

which will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting on June 2, 2025. "These data highlight the critical role the Breast Cancer Index test plays in ...

That event is the 2025 ASCO Annual Meeting, which will take place in three days and will continue through June 3. At it, Bristol-Myers Squibb Company (NYSE:BMY) will again present a fairly wide ...

ASCO convened an Expert Panel and conducted a systematic review of the medical literature published from September 1, 2014, through October 26, 2016. This review builds on two 2015 systematic reviews ...

announced today that new data will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois at 2:30 pm ET on Saturday, May 31st. The presentation ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing ...

will be presented by Eisai at the American Society of Clinical Oncology (ASCO) Congress 2025, held in Chicago, USA from May 30 to June 3, 2025. The abstract of the study has been released today. To ...

today announced the publication of two abstracts on the American Society of Clinical Oncology (ASCO) website in advance of the 2025 ASCO Annual Meeting, taking place May 30-June 3 in Chicago, Illinois ...

A supervised exercise already shown to alleviate fatigue and other side effects in patients with metastatic breast cancer has now been found to also be cost analysis. Anne May, PhD, of Utrecht ...

“The ASCO meeting is an important opportunity to share detailed findings of our positive data from the SURPASS-ET study with the medical community,” said Albert Qin, M.D., Ph.D., Chief Medical ...